Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Butturini

Showing results (131-140 of 168) with videos related to

Pageof 17
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 23, 2023
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trialDavide Melisi, Camilla Zecchetto, Valeria Merz, et al.
Carcinogenesis|August 7, 2016
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patientsCosmeri Rizzato, Daniele Campa, Renata Talar-Wojnarowska, et al.
Annals of Surgery|December 18, 2024
External Validation of the ISGPS Complexity Grading System for Minimally Invasive Pancreatoduodenectomy: Insights from the IGOMIPS registryNiccolò Napoli, Greta Donisi, Emanuele F Kauffmann, et al.
Lancet (London, England)|May 3, 2011
Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trialMarkus K Diener, Christoph M Seiler, Inga Rossion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 studyJuan W Valle, Daniel Palmer, Richard Jackson, et al.
JAMA|September 9, 2010
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trialJohn P Neoptolemos, Deborah D Stocken, Claudio Bassi, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|July 9, 2025
Minimally Invasive Spleen-Preserving Distal Pancreatectomy in Obese Patients: Factors Related to Clinically Relevant Pancreatic FistulaFabio Ausania, Filippo Landi, Carolina González-Abós, et al.
Therapeutic Advances in Medical Oncology|January 6, 2021
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trialFrancesca Simionato, Camilla Zecchetto, Valeria Merz, et al.
Surgical Endoscopy|September 15, 2023
Robotic versus laparoscopic distal pancreatectomy in obese patientsFabio Ausania, Filippo Landi, John B Martinie, et al.
Annals of Surgery|June 6, 2021
Short-term Outcomes After Spleen-preserving Minimally Invasive Distal Pancreatectomy With or Without Preservation of Splenic Vessels: A Pan-European Retrospective Study in High-volume CentersMaarten Korrel, Sanne Lof, Bilal Al Sarireh, et al.
Pageof 17

Showing results (131-140 of 168) with videos related to

Sort By:
Pageof 17
European Journal of Cancer (Oxford, England : 1990)|November 23, 2023
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trialDavide Melisi, Camilla Zecchetto, Valeria Merz, et al.
Carcinogenesis|August 7, 2016
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patientsCosmeri Rizzato, Daniele Campa, Renata Talar-Wojnarowska, et al.
Annals of Surgery|December 18, 2024
External Validation of the ISGPS Complexity Grading System for Minimally Invasive Pancreatoduodenectomy: Insights from the IGOMIPS registryNiccolò Napoli, Greta Donisi, Emanuele F Kauffmann, et al.
Lancet (London, England)|May 3, 2011
Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trialMarkus K Diener, Christoph M Seiler, Inga Rossion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 studyJuan W Valle, Daniel Palmer, Richard Jackson, et al.
JAMA|September 9, 2010
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trialJohn P Neoptolemos, Deborah D Stocken, Claudio Bassi, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|July 9, 2025
Minimally Invasive Spleen-Preserving Distal Pancreatectomy in Obese Patients: Factors Related to Clinically Relevant Pancreatic FistulaFabio Ausania, Filippo Landi, Carolina González-Abós, et al.
Therapeutic Advances in Medical Oncology|January 6, 2021
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trialFrancesca Simionato, Camilla Zecchetto, Valeria Merz, et al.
Surgical Endoscopy|September 15, 2023
Robotic versus laparoscopic distal pancreatectomy in obese patientsFabio Ausania, Filippo Landi, John B Martinie, et al.
Annals of Surgery|June 6, 2021
Short-term Outcomes After Spleen-preserving Minimally Invasive Distal Pancreatectomy With or Without Preservation of Splenic Vessels: A Pan-European Retrospective Study in High-volume CentersMaarten Korrel, Sanne Lof, Bilal Al Sarireh, et al.
Pageof 17